Thursday, May 25, 2017
 

 
 
NEW YORK, May 24, 2017 /PRNewswire-USNewswire/ -- After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency by 39 percent for patients with Dravet syndrome a rare, severe form of epilepsy in the first large-scale randomized clinical trial for the compound. The findin.....   [READ MORE]
 
The Facts on Facial Fillers by Dr. Balikian 

Poets proclaim that wrinkles and furrowed brows show hard-won experien...
  [READ MORE]
 
PUNE, India, May 24, 2017 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Glaucoma - Pipeline Review, H1 2017" to its store providing an overview of the Glaucoma therapeutic pipeline with comprehensive information on the therapeutic development for Glaucoma, complete with comparative analysis at various stages, therapeutic.....   [READ MORE]
PHOENIX and SAN DIEGO, May 24, 2017 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) (the "Company") announced today the filing of a patent application covering a novel means of suppressing inflammation associated with stroke by reprogramming immune cells of the stroke .....   [READ MORE]
 
RESEARCH TRIANGLE PARK, N.C., May 24, 2017 /PRNewswire/ -- Pappas Capital, a life science venture capital firm, announced today that its new fund, Pappas Ventures V, recently invested in OrphoMed, a clinical stage company that is developing best-in-class therapies for treatment of inadequately-controlled gastrointestinal diso.....   [READ MORE]
 
 
MORE NEWS
 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines